Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $15.05 billion. The enterprise value is $14.55 billion.
| Market Cap | 15.05B |
| Enterprise Value | 14.55B |
Important Dates
The next confirmed earnings date is Wednesday, July 22, 2026, after market close.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 28.56 million shares outstanding. The number of shares has decreased by -8.94% in one year.
| Current Share Class | 28.56M |
| Shares Outstanding | 28.56M |
| Shares Change (YoY) | -8.94% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 19.43% |
| Owned by Institutions (%) | 85.91% |
| Float | 23.00M |
Valuation Ratios
The trailing PE ratio is 33.15 and the forward PE ratio is 30.49. MEDP's PEG ratio is 2.29.
| PE Ratio | 33.15 |
| Forward PE | 30.49 |
| PS Ratio | 5.62 |
| Forward PS | 5.42 |
| PB Ratio | 25.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.17 |
| P/OCF Ratio | 20.36 |
| PEG Ratio | 2.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.61, with an EV/FCF ratio of 20.46.
| EV / Earnings | 31.60 |
| EV / Sales | 5.43 |
| EV / EBITDA | 24.61 |
| EV / EBIT | 25.84 |
| EV / FCF | 20.46 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.24.
| Current Ratio | 0.85 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 77.25% and return on invested capital (ROIC) is 475.60%.
| Return on Equity (ROE) | 77.25% |
| Return on Assets (ROA) | 17.47% |
| Return on Invested Capital (ROIC) | 475.60% |
| Return on Capital Employed (ROCE) | 71.75% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | $431,979 |
| Profits Per Employee | $74,258 |
| Employee Count | 6,200 |
| Asset Turnover | 1.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $111.40 million in taxes.
| Income Tax | 111.40M |
| Effective Tax Rate | 19.48% |
Stock Price Statistics
The stock price has increased by +69.40% in the last 52 weeks. The beta is 1.18, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +69.40% |
| 50-Day Moving Average | 450.03 |
| 200-Day Moving Average | 512.77 |
| Relative Strength Index (RSI) | 76.64 |
| Average Volume (20 Days) | 299,577 |
Short Selling Information
The latest short interest is 2.05 million, so 7.20% of the outstanding shares have been sold short.
| Short Interest | 2.05M |
| Short Previous Month | 1.90M |
| Short % of Shares Out | 7.20% |
| Short % of Float | 8.94% |
| Short Ratio (days to cover) | 6.05 |
Income Statement
In the last 12 months, MEDP had revenue of $2.68 billion and earned $460.40 million in profits. Earnings per share was $15.90.
| Revenue | 2.68B |
| Gross Profit | 1.93B |
| Operating Income | 562.92M |
| Pretax Income | 571.80M |
| Net Income | 460.40M |
| EBITDA | 591.02M |
| EBIT | 562.92M |
| Earnings Per Share (EPS) | $15.90 |
Balance Sheet
The company has $652.68 million in cash and $146.09 million in debt, giving a net cash position of $506.59 million or $17.74 per share.
| Cash & Cash Equivalents | 652.68M |
| Total Debt | 146.09M |
| Net Cash | 506.59M |
| Net Cash Per Share | $17.74 |
| Equity (Book Value) | 598.31M |
| Book Value Per Share | 20.95 |
| Working Capital | -205.96M |
Cash Flow
In the last 12 months, operating cash flow was $739.18 million and capital expenditures -$28.18 million, giving a free cash flow of $711.00 million.
| Operating Cash Flow | 739.18M |
| Capital Expenditures | -28.18M |
| Depreciation & Amortization | 28.10M |
| Net Borrowing | n/a |
| Free Cash Flow | 711.00M |
| FCF Per Share | $24.90 |
Margins
Gross margin is 71.90%, with operating and profit margins of 21.02% and 17.19%.
| Gross Margin | 71.90% |
| Operating Margin | 21.02% |
| Pretax Margin | 21.35% |
| Profit Margin | 17.19% |
| EBITDA Margin | 22.07% |
| EBIT Margin | 21.02% |
| FCF Margin | 26.55% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.94% |
| Shareholder Yield | 8.94% |
| Earnings Yield | 3.06% |
| FCF Yield | 4.72% |
Analyst Forecast
The average price target for MEDP is $443.50, which is -15.86% lower than the current price. The consensus rating is "Hold".
| Price Target | $443.50 |
| Price Target Difference | -15.86% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 8.78% |
| EPS Growth Forecast (3Y) | 11.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 6.84 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.84 |
| Piotroski F-Score | 7 |